We reported on 22nd June 2020, that the Secretary of State for Health and Social Care had announced the Government’s plans to change the guidance for the 2.2 million people who have been shielding since the start of the pandemic. Consequently, the Government’s shielding support package, including the Pandemic Delivery Service (both the Terms of Service requirements...
We reported on 22nd June 2020, that the Secretary of State for Health and Social Care had announced the Government’s plans to change the guidance for the 2.2 million people who have been shielding since the start of the pandemic. Consequently, the Government’s shielding support package, including the Pandemic Delivery Service (both the Terms of Service requirements...
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 13 Issue 10 May 2020) has been published and includes articles on: Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection Liposomal and lipid-complex formulations: name change to reduce medication errors Letters and drug alerts sent to healthcare professionals in...
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 13 Issue 10 May 2020) has been published and includes articles on: Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection Liposomal and lipid-complex formulations: name change to reduce medication errors Letters and drug alerts sent to healthcare professionals in...
On 30th July 2020, the UK Chief Medical Officers announced an extension of the self-isolation period from 7 to 10 days. Evidence was cited that shows that people with COVID-19, who are mildly ill and are recovering, have a low but real possibility of infectiousness between 7 and 9 days after illness onset. As a...
Recent Comments